Subscribe Login
DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5
Retail

Walmart Launches Private Label Insulin Treatments Through Healthcare Business

Walmart has commenced the sale of private-label analog insulin this week at a deep discount to branded insulin vials and pens, as it seeks to drive growth at its healthcare business.

The product, ReliOn NovoLog, is a rapid-acting analog insulin used to control high blood sugar in adults and children with diabetes. It will require a prescription from a physician.

The supermarket group, which recently raised its full-year profit forecast, said its more than three million customers with diabetes could save between 58% and 75% off the cash price of branded analog insulin products, or up to $101 per branded vial or $251 per package of branded FlexPen.

“We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions," commented Dr. Cheryl Pegus, executive vice president, Walmart Health & Wellness. We also know this is a condition that disproportionately impacts underserved populations."

Analog insulin tends to be more effective and easier to administer than the older, human insulin.

Tackling Diabetes In Consumers

About one in 10 Americans have diabetes, or roughly 34 million people. The vast majority have type 2 diabetes, a chronic condition linked to genetics, along with weight gain and inactivity. Diet and exercise can help manage the disease, but some patients also need insulin or other medication.

Alternatively, about 1.2 million people have type 1 diabetes, an autoimmune disease that requires lifelong insulin injections after the pancreas stops producing a sufficient amount.

For years, patients, consumer advocates and U.S. lawmakers have complained about the high list prices for insulin and the significant out-of-pocket costs borne by patients.

Walmart, which is working with pharmaceutical company Novo Nordisk, said its products were intended for use by patients with both type 1 and type 2 diabetes.

Lower Prices For Generic Medicine

Bentonville, Arkansas-based Walmart has for years strategically lowered consumer prices for generic medicines, undercutting branded products sold by other retailers.

In 2006, Walmart began selling some generic drugs for $4 per monthly prescription - a tactic soon adopted by a number of pharmacy operators.

"With ReliOn NovoLog insulin, we’re adding a high-quality medication for diabetes to the already affordable ReliOn line of products and continuing our commitment to improve access and lowering cost of care,” Dr Pegus added.

The retailer has also rolled out COVID-19 vaccination schemes across most of the United States.

News by Reuters, edited by ESM. For more Retail news, click here. Click subscribe to sign up to ESM: European Supermarket Magazine.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our Terms & Conditions and Privacy Policy
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days